🇺🇸 FDA
Patent

US 10260054

Engineered organophosphorus acid anhydrolases and methods of use thereof

granted A61KA61K31/4425A61K31/46

Quick answer

US patent 10260054 (Engineered organophosphorus acid anhydrolases and methods of use thereof) held by The United States of America as represented by the Secretary of the Army expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/4425, A61K31/46, A61K31/5513, A61K38/00